Search results query: Phosphorylase Kinase; domain 1

Found 4147 chains in Genus chains table. Displaying 1301 - 1350. Applied filters: Proteins

Total Genus	Sequence Length	pdb	Title
100	356	4y5hA	Pyridopyrimidinone derivatives as potent and selective c-jun n-terminal kinase (jnk) inhibitors
93	316	5cnnA	Crystal structure of the egfr kinase domain mutant i682q
76	275	4ybjA	Type ii dasatinib analog crystallized with c-src kinase
163	472	4y5qA	Activated calcium-dependent protein kinase 1 from cryptosporidium parvum (cpcdpk1) in complex with amp
79	298	4yc3A	Cdk1/cyclinb1/cks2 apo
85	270	4yjvA	The kinase domain of human spleen tyrosine (syk) in complex with gtc000250
127	378	5afvA	Pharmacophore-based virtual screening to discover new active compounds for human choline kinase alpha1.
86	269	4yjsA	The kinase domain of human spleen tyrosine (syk) in complex with gtc000226
82	269	4yc8A	C-helix-out binding of dasatinib analog to c-abl kinase
85	270	4yjqA	Syk kinase domain in complex with inhibitor gtc000224
87	270	4yjrA	Syk kinase domain in complex with inhibitor gtc000225
109	346	4xrjA	Crystal structure of erk2 in complex with an inhibitor
84	275	4xv9A	B-raf kinase domain in complex with plx5568
102	345	4xoyA	Crystal structure of erk2 in complex with an inhibitor
83	270	4xg9A	Crystal structure of an inhibitor-bound syk
84	272	4xg3A	Crystal structure of an inhibitor-bound syk
86	289	4xx9A	Crystal structure of pdk1 in complex with atp and the pif-pocket ligand rf4
114	347	4xozA	Crystal structure of erk2 in complex with an inhibitor
82	274	4xhkB	Pim1 kinase in complex with compound 1s
78	292	4y72A	Human cdk1/cyclinb1/cks2 with inhibitor
113	345	4xrlA	Crystal structure at room temperature of erk2 in complex with an inhibitor
111	347	4xp3A	Crystal structure of erk2 in complex with an inhibitor
80	273	4xh6A	Crystal structure of proto-oncogene kinase pim1 bound to hispidulin
90	274	4xg6A	Crystal structure of an inhibitor-bound syk
87	291	4xcuA	Crystal structure of fgfr4 with an irreversible inhibitor
65	270	4xv3A	B-raf kinase v600e oncogenic mutant in complex with plx7922
104	349	4xj0A	Crystal structure of erk2 in complex with an inhibitor 14k
85	273	4xg2A	Crystal structure of ligand-free syk
93	295	4xyfA	Crystal structure of c-met in complex with (s)-5-(8-fluoro-3-(1-(3-(2-methoxyethoxy)quinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole
76	272	4xv2A	B-raf kinase v600e oncogenic mutant in complex with dabrafenib
111	347	4xp0A	Crystal structure of erk2 in complex with an inhibitor
94	310	4xlvA	Crystal structure of the activated insulin receptor tyrosine kinase dimer
86	273	4xg7A	Crystal structure of an inhibitor-bound syk
93	293	4xbuA	In vitro crystal structure of pak4 in complex with inka peptide
92	295	4xmoA	Crystal structure of c-met in complex with (r)-5-(8-fluoro-3-(1-fluoro-1-(3-methoxyquinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole
100	343	4xbrA	In cellulo crystal structure of pak4 in complex with inka
99	356	4y46A	Pyridopyrimidinone derivatives as potent and selective c-jun n-terminal kinase (jnk) inhibitors
108	346	4xp2A	Crystal structure of erk2 in complex with an inhibitor
79	268	4xliA	Crystal structure of abl2/arg kinase in complex with dasatinib
80	270	4xg8A	Crystal structure of an inhibitor-bound syk
73	297	4xufA	Crystal structure of the flt3 kinase domain bound to the inhibitor quizartinib (ac220)
86	273	4xg4A	Crystal structure of an inhibitor-bound syk
71	268	4xv1A	B-raf kinase v600e oncogenic mutant in complex with plx7904
92	297	4xs2A	Irak4-inhibitor co-structure
107	346	4xneA	Crystal structure of erk2 in complex with an inhibitor
84	273	4xeyA	Crystal structure of an sh2-kinase domain construct of c-abl tyrosine kinase
105	297	4y73A	Crystal structure of irak4 kinase domain with inhibitor
103	337	4x6qC	An isoform-specific myristylation switch targets riib pka holoenzymes to membranes
77	269	4wa9A	The crystal structure of human abl1 wild type kinase domain in complex with axitinib
91	303	4v04A	Fgfr1 in complex with ponatinib.